Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;6(8):e23910.
doi: 10.1371/journal.pone.0023910. Epub 2011 Aug 29.

Understanding original antigenic sin in influenza with a dynamical system

Affiliations

Understanding original antigenic sin in influenza with a dynamical system

Keyao Pan. PLoS One. 2011.

Abstract

Original antigenic sin is the phenomenon in which prior exposure to an antigen leads to a subsequent suboptimal immune response to a related antigen. Immune memory normally allows for an improved and rapid response to antigens previously seen and is the mechanism by which vaccination works. I here develop a dynamical system model of the mechanism of original antigenic sin in influenza, clarifying and explaining the detailed spin-glass treatment of original antigenic sin. The dynamical system describes the viral load, the quantities of healthy and infected epithelial cells, the concentrations of naïve and memory antibodies, and the affinities of naïve and memory antibodies. I give explicit correspondences between the microscopic variables of the spin-glass model and those of the present dynamical system model. The dynamical system model reproduces the phenomenon of original antigenic sin and describes how a competition between different types of B cells compromises the overall effect of immune response. I illustrate the competition between the naïve and the memory antibodies as a function of the antigenic distance between the initial and subsequent antigens. The suboptimal immune response caused by original antigenic sin is observed when the host is exposed to an antigen which has intermediate antigenic distance to a second antigen previously recognized by the host's immune system.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author has declared that no competing interests exist.

Figures

Figure 1
Figure 1. Time courses of the healthy cell concentration , the infected cell concentration , the dead cell concentration , the viral load , the concentrations of naïve and memory antibodies , respectively, and the naïve antibody affinity .
The memory antibody affinity is formula image. The initial conditions are formula image, formula image, formula image, formula image, formula image, and formula image.
Figure 2
Figure 2. Time courses of the healthy cell concentration , the infected cell concentration , the dead cell concentration , the viral load , the concentrations of naïve and memory antibodies , respectively, and the naïve antibody affinity .
The memory antibody affinity is formula image. The initial conditions are the same as those in Figure 1.
Figure 3
Figure 3. Trajectories of the maximum percentage of dead cells, the maximum viral load, the cumulative effects of naïve and memory antibodies defined by equations 9 and 10, respectively, and the final average antibody affinity defined by equation 11 with different memory antibody affinities .
The dashed horizontal lines in (a) and (b) are the maximum percentage of dead cells and the maximum viral load, respectively, at the lowest memory antibody affinity formula image.
Figure 4
Figure 4. Trajectories of the concentration of dead cells and the viral load with different effects of immune response .
In each trajectory, formula image, formula image, formula image, and formula image is constant. When formula image, viruses cannot be cleared at small values of formula image, such as 0.1. The decay rates of both formula image and formula image increase with formula image.
Figure 5
Figure 5. Trajectories of the effect of immune response, .
In each trajectory, formula image, formula image, formula image. Each trajectory corresponds to one value of formula image. When formula image, viruses cannot be cleared at small values of formula image, such as 0.1.
Figure 6
Figure 6. Sensitivity analysis of parameters and .
(a) and (b) The maximum percentages of dead cells and the average antibody affinities at different values of formula image. (c) and (d) The maximum percentages of dead cells and the average antibody affinities at different values of formula image. Initial conditions and parameters other than formula image and formula image are the same as those in Figure 3.
Figure 7
Figure 7. Sensitivity analysis of parameters and .
(a) and (b) The maximum percentages of dead cells and the average antibody affinities at different values of formula image. (c) and (d) The maximum percentages of dead cells and the average antibody affinities at different values of formula image. Initial conditions and parameters other than formula image and formula image are the same as those in Figure 3.

References

    1. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol. 2003;171:4969–4973. - PubMed
    1. Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, et al. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA. 2008;105:14017–14022. - PMC - PubMed
    1. FitzSimons D, Francois G, Hall A, McMahon B, Meheus A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine. 2005;23:4158–4166. - PubMed
    1. Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, et al. Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Negl Trop Dis. 2007;1:e96. - PMC - PubMed
    1. Quan FS, Huang CZ, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol. 2007;81:3514–3524. - PMC - PubMed

Substances